John Andrew Altin

Title: **John Andrew Altin: Innovating Detection Methods in Immunology**

Introduction

John Andrew Altin is a notable inventor based in San Diego, California. He holds four patents, contributing significantly to the field of immunology through innovative detection methods. His work is aimed at enhancing our understanding of peptide binding in relation to MHC (Major Histocompatibility Complex) molecules and T cell receptors.

Latest Patents

Among John Altin's latest patents is a comprehensive method for detecting peptide/MHC/TCR binding. This innovation focuses on providing compositions and techniques for detecting the binding of a peptide to an MHC molecule, as well as the interaction of peptide:MHC complexes with T cell receptors (TCRs). The methods are designed to be highly multiplexed, allowing for the simultaneous detection of a large number of peptides binding to MHC molecules and T cells. Furthermore, these methods facilitate competitive binding assays for numerous peptides, which can be instrumental in vaccine design, research on autoimmune diseases, immunogenicity testing of therapeutics, and tissue typing.

Career Highlights

John is currently employed at Prognosys Biosciences, Inc., where he conducts valuable research in immunology. His expertise in the field is reflected in the advanced techniques he has developed, which are vital for progressing vaccine design and understanding immune responses.

Collaborations

Throughout his career, John has collaborated with notable professionals in his field, including Mark S. Chee and Igor A. Kozlov. These collaborations enhance the depth and impact of his research, leading to innovative solutions and advancements in immunology.

Conclusion

John Andrew Altin’s contributions to the field of immunology through his patents and collaborative efforts underscore his commitment to innovation. His work in developing methods for detecting peptide binding offers promising implications for vaccine research and the monitoring of diseases, setting a foundation for future advancements in medical science.